Inventor
ZHANG BAOSHAN
US31 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG BAOSHAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
29 patentsUS10017543B2Jul 10, 2018
Prefusion RSV F proteins and their use
US HEALTH26 citations92
US9738689B2Aug 22, 2017
Prefusion RSV F proteins and their use
US HEALTH19 citations92
US10420834B2Sep 24, 2019
Recombinant metapneumovirus F proteins and their use
US HEALTH4 citations84
US10035844B2Jul 31, 2018
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein
US HEALTH6 citations83
US9695230B2Jul 4, 2017
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein
US HEALTH9 citations83
US10400015B2Sep 3, 2019
Recombinant HIV-1 envelope proteins and their use
US HEALTH10 citations82
US9475862B2Oct 25, 2016
Neutralizing GP41 antibodies and their use
US HEALTH6 citations82
US11602559B2Mar 14, 2023
HIV-1 Env fusion peptide immunogens and their use
US HEALTH2 citations72
US11078239B2Aug 3, 2021
Prefusion PIV F immunogens and their use
US HEALTH1 citations72
US11878998B2Jan 23, 2024
Prefusion RSV F proteins and their use
US HEALTH2 citations71
US11459360B2Oct 4, 2022
Recombinant HIV-1 envelope proteins and their use
US HEALTH4 citations71
US11174292B2Nov 16, 2021
Substitutions-modified prefusion RSV F proteins and their use
US HEALTH2 citations71
US11130785B2Sep 28, 2021
Prefusion RSV F proteins and their use
US HEALTH2 citations71
US12458691B2Nov 4, 2025
HIV-1 ENV fusion peptide immunogens and their use
US HEALTH0 citations62
US12435113B2Oct 7, 2025
Prefusion PIV F immunogens and their use
US HEALTH0 citations62
US12233124B2Feb 25, 2025
Recombinant metapneumovirus f proteins and their use
US HEALTH0 citations62
US11845778B2Dec 19, 2023
Prefusion PIV F immunogens and their use
US HEALTH0 citations62
US11786591B2Oct 17, 2023
Recombinant metapneumovirus F proteins and their use
US HEALTH0 citations62
US11027007B2Jun 8, 2021
Recombinant metapneumovirus F proteins and their use
US HEALTH0 citations62
US12145968B2Nov 19, 2024
Recombinant HIV-1 envelope proteins and their use
US HEALTH0 citations61
US11981707B2May 14, 2024
Prefusion RSV F proteins and their use
US HEALTH0 citations61
US12275758B2Apr 15, 2025
Prefusion RSV F proteins and their use
US HEALTH0 citations60
US12053519B2Aug 6, 2024
HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use
US HEALTH0 citations59
US12043660B2Jul 23, 2024
10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use
US HEALTH0 citations56
US11236152B2Feb 1, 2022
Neutralizing antibodies to HIV-1 GP41 and their use
US HEALTH0 citations56
US10858400B2Dec 8, 2020
Prefusion RSV F proteins and their use
US HEALTH0 citations51
US10815295B2Oct 27, 2020
Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein
US HEALTH0 citations51
US10047148B2Aug 14, 2018
Neutralizing GP41 antibodies and their use
US HEALTH0 citations50
US9783595B2Oct 10, 2017
Neutralizing GP41 antibodies and their use
US HEALTH0 citations50